These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 9466329)

  • 1. Effects of gonadotropin and testosterone treatments on prostate volume and serum prostate specific antigen levels in male hypogonadism.
    Ozata M; Bulur M; Beyhan Z; Sengül A; Saglam M; Turan M; Corakci A; Ali Gundogan M
    Endocr J; 1997 Oct; 44(5):719-24. PubMed ID: 9466329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of gonadotropin and testosterone treatments on Lipoprotein(a), high density lipoprotein particles, and other lipoprotein levels in male hypogonadism.
    Ozata M; Yildirimkaya M; Bulur M; Yilmaz K; Bolu E; Corakci A; Gundogan MA
    J Clin Endocrinol Metab; 1996 Sep; 81(9):3372-8. PubMed ID: 8784099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of gonadotropin and testosterone treatments on plasma leptin levels in male patients with idiopathic hypogonadotropic hypogonadism and Klinefelter's syndrome.
    Ozata M; Ozisik G; Caglayan S; Yesilova Z; Bingöl N; Saglam M; Turan M; Beyhan Z
    Horm Metab Res; 1998 May; 30(5):266-71. PubMed ID: 9660087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gonadal function and response to human chorionic and menopausal gonadotrophin therapy in male patients with idiopathic hypogonadotrophic hypogonadism.
    Kirk JM; Savage MO; Grant DB; Bouloux PM; Besser GM
    Clin Endocrinol (Oxf); 1994 Jul; 41(1):57-63. PubMed ID: 7914153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two-year comparison of testicular responses to pulsatile gonadotropin-releasing hormone and exogenous gonadotropins from the inception of therapy in men with isolated hypogonadotropic hypogonadism.
    Liu L; Banks SM; Barnes KM; Sherins RJ
    J Clin Endocrinol Metab; 1988 Dec; 67(6):1140-5. PubMed ID: 3142911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidermal growth factor concentrations in seminal plasma from patients with hypogonadism--changes after hormone replacement.
    Fuse H; Okumura M; Sakamoto M; Kazama T; Katayama T
    Urol Int; 1994; 52(1):9-13. PubMed ID: 8140686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Testicular findings, endocrine features and therapeutic responses of men with idiopathic hypogonadotropic hypogonadism].
    Tachiki H; Kumamoto Y; Itoh N; Maruta H; Tsukamoto T
    Nihon Naibunpi Gakkai Zasshi; 1995 May; 71(4):605-22. PubMed ID: 7796925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sex hormone-binding globulin changes with androgen replacement.
    Plymate SR; Leonard JM; Paulsen CA; Fariss BL; Karpas AE
    J Clin Endocrinol Metab; 1983 Sep; 57(3):645-8. PubMed ID: 6683724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Testicular function during puberty and young adulthood in patients with Klinefelter's syndrome with and without spermatozoa in seminal fluid.
    Rohayem J; Nieschlag E; Zitzmann M; Kliesch S
    Andrology; 2016 Nov; 4(6):1178-1186. PubMed ID: 27611179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Daytime plasma melatonin levels in male hypogonadism.
    Ozata M; Bulur M; Bingol N; Beyhan Z; Corakci A; Bolu E; Gundogan MA
    J Clin Endocrinol Metab; 1996 May; 81(5):1877-81. PubMed ID: 8626851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Testosterone undecanoate supplementation together with human chorionic gonadotropin does not impair spermatogenesis in males with isolated hypogonadotropic hypogonadism: a retrospective study.
    Chen YW; Niu YH; Xu H; Wang DQ; Jiang HY; Pokhrel G; Wang T; Wang SG; Liu JH
    Asian J Androl; 2019; 21(4):413-418. PubMed ID: 30604694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Failure of combined follicle-stimulating hormone-testosterone administration to initiate and/or maintain spermatogenesis in men with hypogonadotropic hypogonadism.
    Schaison G; Young J; Pholsena M; Nahoul K; Couzinet B
    J Clin Endocrinol Metab; 1993 Dec; 77(6):1545-9. PubMed ID: 8263139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pulsatile GnRH or human chorionic gonadotropin/human menopausal gonadotropin as effective treatment for men with hypogonadotropic hypogonadism: a review of 42 cases.
    Büchter D; Behre HM; Kliesch S; Nieschlag E
    Eur J Endocrinol; 1998 Sep; 139(3):298-303. PubMed ID: 9758439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Male hypogonadotropic hypogonadism: factors influencing response to human chorionic gonadotropin and human menopausal gonadotropin, including prior exogenous androgens.
    Ley SB; Leonard JM
    J Clin Endocrinol Metab; 1985 Oct; 61(4):746-52. PubMed ID: 3928676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of oestrogen administration on plasma testosterone, FSH and LH levels in patients with Klinefelter's syndrome and normal men.
    Smals AG; Kloppenborg PW; Lequin RM; Benraad TJ
    Acta Endocrinol (Copenh); 1974 Dec; 77(4):765-83. PubMed ID: 4479709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostate-specific antigen (PSA) concentrations in hypogonadal men during 6 years of transdermal testosterone treatment.
    Raynaud JP; Gardette J; Rollet J; Legros JJ
    BJU Int; 2013 May; 111(6):880-90. PubMed ID: 23294726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Late-onset hypogonadism: the advantages of treatment with human chorionic gonadotropin rather than testosterone.
    La Vignera S; Condorelli RA; Cimino L; Russo GI; Morgia G; Calogero AE
    Aging Male; 2016; 19(1):34-9. PubMed ID: 26488941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Testosterone normalizes plasma vasopressin response to osmotic stimuli in men with hypogonadism.
    Ikeda Y; Tanaka I; Oki Y; Gemmma R; Morita H; Komatsu K; Yoshimi T
    Endocr J; 1993 Aug; 40(4):387-92. PubMed ID: 7920892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A case report of idiopathic hypogonadotropic hypogonadism with particular reference to monitoring of prostate volume].
    Hirayama K; Okada K; Kanemitsu N; Kojima M; Hayase Y
    Hinyokika Kiyo; 2004 Jul; 50(7):501-4. PubMed ID: 15334897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Testosterone replacement therapy and prostate/seminal vesicle volume in Klinefelter's syndrome.
    Sasagawa I; Nakada T; Kazama T; Terada T; Katayama T
    Arch Androl; 1989; 22(3):245-9. PubMed ID: 2502953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.